Skip to content

Model suggests there are fewer people with HIV in the US than thought, and more of them on therapy

Low-cost generic hepatitis C drugs match branded products in viral response

Dr James Freeman presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com

$300 hepatitis C combination to enter clinical trials

Primary care doctors and nurse practitioners can successfully treat people with hepatitis C

More people with HIV are achieving viral suppression in US, but about 40% remain above transmission thresholds

Heather Bradley presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Indian study proves that more people virally suppressed in a population equals fewer HIV infections

No adverse social consequences from early ART initiation in West Africa

Tailored programmes encourage black gay men to start and stay on PrEP in US study

Darrell Wheeler presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

England’s PrEP policy in disarray after NHS U-turn